Victor Test is a Respiratory physician affiliated with Texas Tech University. OpenAlex indexes 86 publications with 764 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Texas Tech Physicians
3601 4th Street Stop 9410
Lubbock, TX 794309410
Telephone
806-743-3150Provider last certified this registry record 7 Feb 2025.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
- Insmed, Inc.Program year20251 payment
- Aimmune Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.9%Endothelin Receptor Antagonist17.9%Opsumit69%Ambrisentan24%Opsynvi7%Part D<11 patientsLoop diuretic10%Furosemide77%Bumetanide12%Torsemide12%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
17.2%SGLT2 inhibitor9.2%Jardiance89%Farxiga11%Part D<11 patientsCorticosteroid3%Prednisone100%Part D≥24 patients+ 2 more classes in this area
Genitourinary & hormones
13.2%Phosphodiesterase 5 Inhibitor13.2%Tadalafil51%Sildenafil Citrate45%Alyq4%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The utility of brain natriuretic peptide in patients undergoing an initial evaluation for pulmonary hypertension
Journal of Community Hospital Internal Medicine Perspectives
2022 - The clinical associations with cardiomegaly in patients undergoing evaluation for pulmonary hypertension
Journal of Community Hospital Internal Medicine Perspectives
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Javier Corral, MD
Texas Tech University
Marc Zuckerman, MD
Texas Tech University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”